Endometrial Clear Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Endometrial Clear Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of Onapristone and Anastrozole for refractory hormone receptor-positive endometrial cancer…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: A Study of Nivolumab in Selected Uterine Cancer Patients [Phase 2]
Phase 2 study of Nivolumab in selected uterine cancers has completed enrollment and posted results in 2024.
-
CLINICAL_TRIALS trial_result · 2016-08-15Clinical Trial Update: Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium [Phase 2]
A Phase 2 trial is comparing nintedanib against chemotherapy in patients with recurrent ovarian clear cell carcinoma or recurrent endometria…
-
CLINICAL_TRIALS trial_result · 2016-02-05Clinical Trial Update: Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
A Phase 2 clinical trial evaluating dalantercept for recurrent or persistent endometrial cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer [Phase 2]
A Phase 2 clinical trial evaluated temsirolimus in patients with metastatic or locally advanced recurrent endometrial cancer, with results p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
Phase 2 trial evaluating thalidomide in patients with recurrent or persistent endometrial cancer has completed.